<code id='91A1A4CFE3'></code><style id='91A1A4CFE3'></style>
    • <acronym id='91A1A4CFE3'></acronym>
      <center id='91A1A4CFE3'><center id='91A1A4CFE3'><tfoot id='91A1A4CFE3'></tfoot></center><abbr id='91A1A4CFE3'><dir id='91A1A4CFE3'><tfoot id='91A1A4CFE3'></tfoot><noframes id='91A1A4CFE3'>

    • <optgroup id='91A1A4CFE3'><strike id='91A1A4CFE3'><sup id='91A1A4CFE3'></sup></strike><code id='91A1A4CFE3'></code></optgroup>
        1. <b id='91A1A4CFE3'><label id='91A1A4CFE3'><select id='91A1A4CFE3'><dt id='91A1A4CFE3'><span id='91A1A4CFE3'></span></dt></select></label></b><u id='91A1A4CFE3'></u>
          <i id='91A1A4CFE3'><strike id='91A1A4CFE3'><tt id='91A1A4CFE3'><pre id='91A1A4CFE3'></pre></tt></strike></i>

          Home / Wikipedia / hotspot

          hotspot


          hotspot

          author:Wikipedia    Page View:2794
          Alexis Borisy
          Venture capitalist Alexis Borisy Vanessa Leroy for STAT

          EQRx is done, sold for its cash.

          The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

          advertisement

          The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In